Comparison of Helicobacter Pylori Eradication using Quadruple Regimens in Dyspeptic Patients

Publish Year: 1392
نوع سند: مقاله ژورنالی
زبان: English
View: 185

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ZUMS-21-86_001

تاریخ نمایه سازی: 11 اردیبهشت 1400

Abstract:

Background and Objective: An optimal regimen for treatment of Helicobacter pylori should have high efficacy, tolerable side effects, easy administration and should be economical. Intensive efforts are being made to identify such an optimal regimen, but there are many obstacles hindering the achievement of this goal. This study aimed at comparing the rate of HP eradication by examining quadruple regimens in dyspeptic patients. Materials and Methods: In this open-label randomized clinical trial, ۲۷۰ patients with positive Urease test were randomly assigned into four groups to receive one of the following treatment protocols. ( group A: omeprazole+ amoxicillin+ bismuth subcitrate+clarithromycin for ۲ weeks (۷۳ patients), group B: omeprazole+tetracycline+bismuth subcitrate+metronidazole for ۲ weeks (۴۶ patients), group C: omeprazole+amoxicillin+bismuth subcitrate+furazolidone for ۲ weeks (۶۴ patients), groupD: omeprazole+amoxicillin+bismuth subcitrate+furazolidone/metronidazole interchangeably each one for one week (۸۷ patients). Six weeks after the treatment, the compliance, eradication and complication rates were evaluated in each group. Results: Helicobacter pylori eradication rates were, ۹۶.۳%, ۸۷%, ۷۹.۷%, and ۷۹.۳ % in groups A, B, C and D respectively (p=۰.۵۰۶). The overall complication rate was ۳۷%, ۶۳%, ۳۲.۸% and ۲۸.۷% in groups A, B, C and D respectively. This rate was significantly higher in group B than other groups (p=۰.۰۱). The compliance rate was “complete”, ‘good” or “poor”. Accordingly the compliance rate in group A was ۸۳.۶%, ۱۱% and ۵.۵%, in group B, ۸۷%, ۶.۵% and ۶.۵%, in group C. ۹۰.۶%, ۴.۷% and ۴.۷%, and in group D ۸۶.۲%, ۱۱.۵% and ۲.۳%, respectively (p=۰.۶۸۳). Abdominal pain and vomiting was significantly more frequent in groups B and C compared to the other groups. The other complications were not significantly different in the groups. Conclusion: The rate of compliance and HP eradication was similar in quadruple regimens however, due to difference in the rate of complications, regimens of groups A or D are recommended.

Authors

ابراهیم فتاحی

Liver and Gastrointestinal Diseases Research Centre, University of Medical Sciences, Tabriz, Iran

محمدحسین صومی

Liver and Gastrointestinal Diseases Research Centre, University of Medical Sciences, Tabriz, Iran

علیرضا غمخوار

Liver and Gastrointestinal Diseases Research Centre, University of Medical Sciences, Tabriz, Iran

علی قویدل

Liver and Gastrointestinal Diseases Research Centre, University of Medical Sciences, Tabriz, Iran

اشرف فخرجو

Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran

شیرین فتاحی

Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran

شهناز نقاشی

Liver and Gastrointestinal Diseases Research Centre, University of Medical Sciences, Tabriz, Iran